Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8257)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(16): 4933-4945 [PMID: PMC4408466 DOI: 10.3748/wjg.v21.i16.4933] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i16/4933.htm |
| Number | Citing Articles |
| 1 |
Ziming He, Di Tang. Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1230164
|
| 2 |
Xiaobin Feng, Peipei Song, Ping Bie, Peng Jiang, Kuansheng Ma, Xiaowu Li, Shuguang Wang, Zhigang Wang, Wei Tang, Shuguo Zheng. Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery. Medical Science Monitor 2016; 22: 1663 doi: 10.12659/MSM.895483
|
| 3 |
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
|
| 4 |
Murtadha M Jawad, Arshad N Aldujaili. Study of the effect of the phenolic extract of the Urtica dioica the level of Des-gamma-prothrombin after treatment with carbon tetrachloride. Journal of Physics: Conference Series 2019; 1294(6): 062031 doi: 10.1088/1742-6596/1294/6/062031
|
| 5 |
Narongsak Rungsakulkij, Wikran Suragul, Somkit Mingphruedhi, Pongsatorn Tangtawee, Paramin Muangkaew, Suraida Aeesoa. Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection. Infectious Agents and Cancer 2018; 13(1) doi: 10.1186/s13027-018-0192-7
|
| 6 |
Hyunyou Kim, So Jeong Lee, Myunghee Yoon. Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy. Annals of Surgical Treatment and Research 2020; 98(4): 168 doi: 10.4174/astr.2020.98.4.168
|
| 7 |
Mehran Afshar, Peter Fletcher, Antonio D Bardoli, Yuk Ting Ma, Pankaj Punia. Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort. Oncotarget 2018; 9(24): 16988 doi: 10.18632/oncotarget.24769
|
| 8 |
Seham A. Omar, Nahla M. Attia, Mohamed I. Sheir, Ayman s. Amer, Mohamed M. EL Shabrawy, Basma B. Hasan. Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?. European Journal of Gastroenterology & Hepatology 2021; 33(7): 1015 doi: 10.1097/MEG.0000000000002074
|
| 9 |
Shin Hwang, Deok-Bog Moon, Ki-Hun Kim, Chul-Soo Ahn, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Gastrointestinal Surgery 2021; 25(7): 1745 doi: 10.1007/s11605-020-04800-6
|
| 10 |
Kei Moriya, Tadashi Namisaki, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Naotaka Shimozato, Yasuhiko Sawada, Akitoshi Douhara, Shinya Sato, Masanori Furukawa, Koh Kitagawa, Takemi Akahane, Hitoshi Yoshiji. Identification of the Response-Related Biomarker of Bimonthly Hepatic Arterial Infusion Chemotherapy. Journal of Clinical Medicine 2021; 10(4): 629 doi: 10.3390/jcm10040629
|
| 11 |
Bo Li, Aixia Liu, Yi Wen, Guang Yang, Jing Zhao, Xiaohan Li, Yuanli Mao, Boan Li. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data. Journal of Clinical Laboratory Analysis 2021; 35(9) doi: 10.1002/jcla.23932
|
| 12 |
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stages. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 55 doi: 10.16931/1995-5464.2020255-66
|
| 13 |
Su-Ming Zhao, Li-Wei Qiu, Hui Zhao, Wei-Wei Gu, Xiao-Hu Yang, Zhu-Xing Gu, Rong-Feng Shi, Cai-Fang Ni. Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors. Journal of Cancer Research and Therapeutics 2021; 17(3): 707 doi: 10.4103/jcrt.JCRT_651_20
|
| 14 |
Gil-Chun Park, Shin Hwang, Yo-Han Park, Jin-Uk Choi. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database. Annals of Surgical Treatment and Research 2020; 98(5): 235 doi: 10.4174/astr.2020.98.5.235
|
| 15 |
Lorenz Kocheise, Martin Schoenlein, Berit Behrends, Vincent Joerg, Christian Casar, Thorben W. Fruendt, Thomas Renné, Asmus Heumann, Jun Li, Samuel Huber, Ansgar W. Lohse, Klaus Pantel, Sabine Riethdorf, Henning Wege, Kornelius Schulze, Johann von Felden. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47580-0
|
| 16 |
Shin Hwang, Gi-Won Song, Young-Joo Lee, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2016; 20(11): 1807 doi: 10.1007/s11605-016-3187-y
|
| 17 |
Yanying Wang, Ying Qu, XiaoXue Ye, Kangbing Wu, Chunya Li. Fabrication of an electrochemical immunosensor for α-fetoprotein based on a poly-L-lysine-single-walled carbon nanotubes/Prussian blue composite film interface. Journal of Solid State Electrochemistry 2016; 20(8): 2217 doi: 10.1007/s10008-016-3229-0
|
| 18 |
Jianping Sun, Yanan Zhao, Ling Qin, Kang Li, Yan Zhao, Huanqin Sun, Ting Zhang, Yonghong Zhang. Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01069
|
| 19 |
Karim J. Halazun, Marc Najjar, Rita M. Abdelmessih, Benjamin Samstein, Adam D. Griesemer, James V. Guarrera, Tomoaki Kato, Elizabeth C. Verna, Jean C. Emond, Robert S. Brown. Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Annals of Surgery 2017; 265(3): 557 doi: 10.1097/SLA.0000000000001966
|
| 20 |
Jingqi Liu, Chengyu Fang, Xinyan Jin, Guo Tian, Zhongxia Sun, Lijie Hong, Jinhua Pan, Xinhua Chen, Jun Zhao, Hongcui Cao, Tianan Jiang. Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2+ mononuclear phagocyte differentiation in liver cancer. Molecular Oncology 2023; 17(6): 1093 doi: 10.1002/1878-0261.13372
|
| 21 |
Xincheng Liu, Yu Huang, Chenglong Jiang, Huohui Ou, Botang Guo, Hui Liao, Xianghong Li, Dinghua Yang. Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma. Digestive and Liver Disease 2016; 48(8): 953 doi: 10.1016/j.dld.2016.04.015
|
| 22 |
Xin-Xing Hu, Wen-Tao Wang, Li Yang, Zhao-Xia Yang, He-Yue Liang, Ying Ding, Yuan Ji, Meng-Su Zeng, Sheng-Xiang Rao. MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas. European Journal of Radiology 2019; 113: 7 doi: 10.1016/j.ejrad.2019.01.036
|
| 23 |
Tatsuya Orimo, Toshiya Kamiyama, Kenji Wakayama, Shingo Shimada, Akihisa Nagatsu, Yoh Asahi, Yuzuru Sakamoto, Hirofumi Kamachi, Akinobu Taketomi. Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2020; 27(11): 4153 doi: 10.1245/s10434-020-08754-6
|
| 24 |
Hongbin Zhang, Siyuan Chai, Lintao Chen, Yubizhuo Wang, Yongna Cheng, Quan Fang, Guosen Wu, Xiangming Wang, Wenjie Liang, Wenbo Xiao. MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.611738
|
| 25 |
Bianca Magro, Domenico Pinelli, Massimo De Giorgio, Maria Grazia Lucà, Arianna Ghirardi, Alessandra Carrobio, Giuseppe Baronio, Luca Del Prete, Franck Nounamo, Andrea Gianatti, Michele Colledan, Stefano Fagiuoli. Pre-Transplant Alpha-Fetoprotein > 25.5 and Its Dynamic on Waitlist Are Predictors of HCC Recurrence after Liver Transplantation for Patients Meeting Milan Criteria. Cancers 2021; 13(23): 5976 doi: 10.3390/cancers13235976
|
| 26 |
Yoshitaka Saegusa, Yuki Imaoka, Masahiro Ohira, Tsuyoshi Kobayashi, Naruhiko Honmyo, Michinori Hamaoka, Takashi Onoe, Daisuke Takei, Koichi Oishi, Tomoyuki Abe, Toshihiro Nakayama, Miho Akabane, Kazunari Sasaki, Hideki Ohdan. Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study. Journal of Gastrointestinal Surgery 2025; 29(4): 101980 doi: 10.1016/j.gassur.2025.101980
|
| 27 |
Tony El Jabbour, Stephen M Lagana, Hwajeong Lee. Update on hepatocellular carcinoma: Pathologists’ review. World Journal of Gastroenterology 2019; 25(14): 1653-1665 doi: 10.3748/wjg.v25.i14.1653
|
| 28 |
Chenjun Huang, Meng Fang, Xiao Xiao, Hong Wang, Zhiyuan Gao, Jun Ji, Lijuan Liu, Erli Gu, Ya Li, Mengmeng Wang, Chunfang Gao. Validation of the GALAD model for early diagnosis and monitoring of hepatocellular carcinoma in Chinese multicenter study. Liver International 2022; 42(1): 210 doi: 10.1111/liv.15082
|
| 29 |
Eva Juárez-Hernández, Daniel Motola-Kuba, Norberto Carlos Chávez-Tapia, Misael Uribe, Varenka Barbero Becerra. Biomarkers in hepatocellular carcinoma: an overview. Expert Review of Gastroenterology & Hepatology 2017; 11(6): 549 doi: 10.1080/17474124.2017.1311785
|
| 30 |
Shujing Huang, Feifei Jiang, Ying Wang, Yanhua Yu, Siqian Ren, Xiaowei Wang, Peng Yin, Jinli Lou. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients. Tumor Biology 2017; 39(6): 101042831770576 doi: 10.1177/1010428317705763
|
| 31 |
Xiaoxue Wu, Mengchao Wei, Yong Chen, Zhenwei Peng. Surgery or external beam radiation for solitary small hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 2023; 19(Suppl 1): S166 doi: 10.4103/jcrt.JCRT_1604_20
|
| 32 |
Ningning Lu, Shugui Sheng, Yiqi Xiong, Chuanren Zhao, Wenying Qiao, Xiaoyan Ding, Jinglong Chen, Yonghong Zhang. Prognostic model for predicting recurrence in hepatocellular carcinoma patients with high systemic immune-inflammation index based on machine learning in a multicenter study. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1459740
|
| 33 |
Xinrong Jiang, Liye Tao, Shuo Cao, Zhengao Xu, Shuang Zheng, Huafang Zhang, Xinran Xu, Xuetong Qu, Xingyue Liu, Jiekai Yu, Xiaoming Chen, Jianmin Wu, Xiao Liang. Porous Silicon Particle-Assisted Mass Spectrometry Technology Unlocks Serum Metabolic Fingerprints in the Progression From Chronic Hepatitis B to Hepatocellular Carcinoma. ACS Applied Materials & Interfaces 2025; 17(4): 5893 doi: 10.1021/acsami.4c17563
|
| 34 |
Takeshi Ichikawa, Nobuaki Machida, Hiroshi Sasaki, Akira Tenmoku, Hiroaki Kaneko, Ryoju Negishi, Itaru Oi, Masayuki A. Fujino. Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization. Oncology 2016; 91(6): 317 doi: 10.1159/000448999
|
| 35 |
Suk Kyun Hong, Xue‐Li Jin, Sanggyun Suh, Su young Hong, Kwangpyo Hong, Eui Soo Han, Jeong‐Moo Lee, YoungRok Choi, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh. Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma. World Journal of Surgery 2022; 46(1): 197 doi: 10.1007/s00268-021-06308-9
|
| 36 |
Nadia Ahmed, Kevin Benny, Sohail Siraj, Hufsa Ali, Riyaz Basha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 287 doi: 10.1016/B978-0-323-99283-1.00002-1
|
| 37 |
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget 2017; 8(33): 55715 doi: 10.18632/oncotarget.18382
|
| 38 |
Rong Wu, Xiao-Yan Li, Wen-Hai Wang, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Qiu-Sha Pan, Qi-Long Chen, Rong-Yao Zhou, Shi-Bing Su. Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/3242989
|
| 39 |
Hao Xing, Cunling Yan, Liming Cheng, Nianyue Wang, Shuyang Dai, Jianyong Yuan, Wenfeng Lu, Zhouchong Wang, Jun Han, Yijie Zheng, Tian Yang. Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma. Tumor Biology 2016; 37(12): 15447 doi: 10.1007/s13277-016-5443-x
|